Nevalainen Timo J, Graham Garry G, Scott Kieran F
Department of Pathology, University of Turku, Kiinamyllynkatu 10, FIN-20520 Turku, Finland.
Biochim Biophys Acta. 2008 Jan-Feb;1781(1-2):1-9. doi: 10.1016/j.bbalip.2007.12.001. Epub 2007 Dec 15.
Antibacterial properties of secreted phospholipases A2 (PLA2) have emerged gradually. Group (G) IIA PLA2 is the most potent among mammalian secreted (s) PLA2s against Gram-positive bacteria, but additional antibacterial compounds, e.g. the bactericidal/permeability-increasing protein, are needed to kill Gram-negative bacteria. The mechanisms of binding to the bacterial surface and the killing of bacteria by sPLA2s are based on the positive charge of the PLA2 protein and its phospholipolytic enzymatic activity, respectively. The concentration of GIIA PLA2 is highly elevated in serum of patients with bacterial sepsis, and overexpression of GIIA PLA(2) protects transgenic mice against experimental Gram-positive infection. The synthesis and secretion of GIIA PLA2 are stimulated by the cytokines TNF-alpha, IL-1 and IL-6. Secreted PLA2s may be potentially useful new endogenous antibiotics to combat infections including those caused by antibiotic-resistant bacteria such as methicillin-resistant staphylococci and vancomysin-resistant enterococci.
分泌型磷脂酶A2(PLA2)的抗菌特性已逐渐显现。在哺乳动物分泌型(s)PLA2中,IIA组PLA2对革兰氏阳性菌的抗菌能力最强,但要杀灭革兰氏阴性菌还需要其他抗菌化合物,如杀菌/通透性增加蛋白。sPLA2与细菌表面结合以及杀灭细菌的机制分别基于PLA2蛋白的正电荷及其磷脂水解酶活性。在细菌性败血症患者的血清中,GIIA PLA2的浓度会大幅升高,GIIA PLA2的过表达可保护转基因小鼠免受实验性革兰氏阳性菌感染。细胞因子TNF-α、IL-1和IL-6可刺激GIIA PLA2的合成与分泌。分泌型PLA2可能是对抗感染(包括由耐抗生素细菌如耐甲氧西林葡萄球菌和耐万古霉素肠球菌引起的感染)的潜在有用的新型内源性抗生素。